SPONSORED:

Bipartisan leaders of House panel press drug companies on opioid crisis

Bipartisan leaders of House panel press drug companies on opioid crisis
© Getty

Bipartisan leaders of the House Energy and Commerce Committee are pressing three drug companies for answers about their role in the opioid crisis.

The panel’s leaders sent letters to three companies that make opioids, Insys Therapeutics, Mallinckrodt Pharmaceuticals and Purdue Pharma, requesting a briefing with the committee and answers to questions about how the companies marketed opioids and whether they looked the other way when they saw evidence of abuse of their products.

Purdue Pharma, the maker of OxyContin, has long been under scrutiny for misleadingly marketing its product as nonaddictive. The company pleaded guilty in 2007 to misrepresenting the drug’s addictive qualities.

ADVERTISEMENT

The committee’s letter to Purdue questions whether the company actually changed its marketing behavior after 2007.

The letter also points to evidence in media reports that the company knew the drug was being abused earlier than 2000, when officials have said they learned about the problem.

“If Purdue personnel were in fact aware of reports of OxyContin being abused prior to 2000, then that may call into question testimony company executives provided to Congress, including before this Committee,” the lawmakers write.

Earlier this year, Purdue said it would stop marketing opioids to doctors and laid off its sales force.

The letter was signed by the panel’s Chairman, Greg WaldenGregory (Greg) Paul WaldenLobbying world Give Republicans the climate credit they deserve Fox hires former GOP lawmaker Greg Walden as political consultant MORE (R-Ore.), as well as ranking member Frank Pallone Jr.Frank Joseph PalloneIntercept bureau chief: Democrats dropping support of Medicare for All could threaten bill's momentum House Democrats reintroduce road map to carbon neutrality by 2050 House Democrats criticize Texas's 'shortcomings in preparations' on winter storms MORE (D-N.J.) and Reps. Gregg HarperGregory (Gregg) Livingston HarperEthics watchdog: 'Substantial' evidence GOP lawmaker improperly spent funds, misused position to help brother Congress sends bill overhauling sexual harassment policy to Trump's desk Dems cry foul in undecided N.C. race MORE (R-Miss.), Diana DeGetteDiana Louise DeGetteDemocrats target Trump methane rule with Congressional Review Act Regulator: Evidence suggests Texas 'absolutely' didn't follow recommendations to winterize power equipment Democrats urge FDA to clear market of all flavored e-cigarettes MORE (D-Colo.), Morgan GriffithHoward (Morgan) Morgan GriffithGOP lawmakers press social media giants for data on impacts on children's mental health Lawmakers press federal agencies on scope of SolarWinds attack House Republicans urge Democrats to call hearing with tech CEOs MORE (R-Va.) and Kathy CastorKatherine (Kathy) Anne CastorHillicon Valley: Tech companies duke it out at Senate hearing | Seven House Republicans vow to reject donations from Big Tech Markey, Castor urge FTC to investigate Google Play Store Lawmakers react to guilty verdict in Chauvin murder trial: 'Our work is far from done' MORE (D-Fla.).

The committee has been investigating the opioid crisis for months, including looking into “pill dumping,” where drug distributors flooded small towns, particularly in West Virginia, with millions of opioid pills.